Joachim Burman

Joachim Burman

UNVERIFIED PROFILE

Are you Joachim Burman?   Register this Author

Register author
Joachim Burman

Joachim Burman

Publications by authors named "Joachim Burman"

Are you Joachim Burman?   Register this Author

35Publications

585Reads

38Profile Views

Profound but transient changes in the inflammatory milieu of the blood during autologous hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2019 Sep 13. Epub 2019 Sep 13.

Department of Neuroscience, Uppsala University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.010DOI Listing
September 2019

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Mult Scler 2019 Aug 8:1352458519866600. Epub 2019 Aug 8.

Department of Clinical Neuroscience, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519866600DOI Listing
August 2019

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.

Acta Neurol Scand 2019 Jul 12. Epub 2019 Jul 12.

Department of Neuroscience, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13147DOI Listing
July 2019

Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis.

Mult Scler 2019 Jul 26:1352458519863983. Epub 2019 Jul 26.

Department of Neuroscience, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519863983DOI Listing
July 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

JAMA Neurol 2019 Jun 17. Epub 2019 Jun 17.

UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2019.1534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580449PMC
June 2019

Container-based bioinformatics with Pachyderm.

Bioinformatics 2019 Mar;35(5):839-846

Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bioinformatics/bty699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394392PMC
March 2019

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing⁻Remitting Multiple Sclerosis.

Cells 2019 01 24;8(2). Epub 2019 Jan 24.

Department of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8020084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406712PMC
January 2019

Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.

Neurology 2018 11 10;91(20):e1893-e1901. Epub 2018 Oct 10.

From the Department of Pharmacology and Clinical Neuroscience (J. Bergman, J.D.G., T.B., A.S.), Umeå University; Department of Neurosciences (J. Burman, E.J.), Uppsala University; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, Queen Square; UK Dementia Research Institute at UCL (H.Z.), London; and Department of Clinical Sciences (A.S.), Karolinska Institute Danderyd Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006500DOI Listing
November 2018

Treatment of epilepsy in multiple sclerosis.

Seizure 2018 May 5;58:47-51. Epub 2018 Apr 5.

Department of clinical neuroscience, Sahlgrenska Academy, University of Gothenburg, Sweden; Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.seizure.2018.04.001DOI Listing
May 2018

Autologous haematopoietic stem cell transplantation for neurological diseases.

J Neurol Neurosurg Psychiatry 2018 02 2;89(2):147-155. Epub 2017 Sep 2.

Department of Neuroscience, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2017-316271DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800332PMC
February 2018

Epilepsy in multiple sclerosis: A nationwide population-based register study.

Neurology 2017 Dec 8;89(24):2462-2468. Epub 2017 Nov 8.

From the Department of Neuroscience (J.B.), Uppsala University; and Department of Clinical Neuroscience (J.Z.), Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004740DOI Listing
December 2017

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

Blood Adv 2017 12 20;1(27):2742-2755. Epub 2017 Dec 20.

Unité Clinique de Médecine Interne, Maladies Auto-immunes et Pathologie Vasculaire, Unité Fonctionnelle 04, Hôpital Saint-Louis, AP-HP, INSERM Unité Mixte de Recherche Scientifique 1160, Paris Denis Diderot University, Paris, France; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2017010041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745133PMC
December 2017

Blogs cannot separate wheat from chaff.

Science 2017 11;358(6363):602

Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aar2575DOI Listing
November 2017

Autologous hematopoietic stem cell transplantation for MS: Safer than previously thought.

Neurology 2017 05 28;88(22):2072-2073. Epub 2017 Apr 28.

From the Department of Neuroscience (J.B.), Uppsala University, Sweden; and Mellen Center for Multiple Sclerosis (R.J.F.), Neurological Institute, Cleveland Clinic, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003995DOI Listing
May 2017

Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab.

Mult Scler Relat Disord 2017 Feb 24;12:82-87. Epub 2017 Jan 24.

Department of Neuroscience, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2017.01.009DOI Listing
February 2017

A Comparison of Botox 100 U/mL and Dysport 100 U/mL Using Dose Conversion Ratio 1: 3 and 1: 1.7 in the Treatment of Cervical Dystonia: A Double-Blind, Randomized, Crossover Trial.

Clin Neuropharmacol 2015 Sep-Oct;38(5):170-6

*Department of Neuroscience, Neurology and †Department of Neuroscience, Physiotherapy, Uppsala University, Uppsala; and ‡Department of Clinical Neuroscience, Neurology R3:04, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/clinicalneuropharm/2015/09000/A
Web Search
http://dx.doi.org/10.1097/WNF.0000000000000101DOI Listing
June 2016

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

J Neuroimmunol 2016 Mar 16;292:40-4. Epub 2016 Jan 16.

Department of Pharmacology and Clinical Neuroscience, Umeå University and University Hospital of Northern Sweden, Umeå, Sweden; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2016.01.008DOI Listing
March 2016

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.

J Neuroimmunol 2016 Mar 22;292:52-7. Epub 2016 Jan 22.

Department of Clinical Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2016.01.013DOI Listing
March 2016

The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.

J Neuroimmunol 2014 Dec 18;277(1-2):153-9. Epub 2014 Oct 18.

Department of Immunology, Genetics and Pathology, Science for Life Laboratories, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.005DOI Listing
December 2014

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

J Neurol Neurosurg Psychiatry 2014 Oct 19;85(10):1116-21. Epub 2014 Feb 19.

Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2013-307207DOI Listing
October 2014

T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Immunology 2013 Oct;140(2):211-9

Department of Neurosciences, Uppsala University, Uppsala, Sweden; Department of Neurology, Uppsala University Hospital, Uppsala, Sweden; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imm.12129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3784167PMC
October 2013

T regulatory cells lacking CD25 are increased in MS during relapse.

Autoimmunity 2010 Dec 7;43(8):590-7. Epub 2010 Apr 7.

Clinical Immunology division, Uppsala University, Uppsala, 751 85, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08916930903541190DOI Listing
December 2010